The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS™ Lysing Solution (Cat. No. 349202) and stained with PE Mouse IgG2a, κ Isotype Control (Cat. No. 555574; dashed line histogram) or with PE Mouse Anti-Human HLA-DR (Cat. No. 555812/560943; solid line histogram). Fluorescent histograms showing expression of HLA-DR (or Ig isotype staining) were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan™ system.
Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS™ Lysing Solution (Cat. No. 349202) and stained with PE Mouse IgG2a, κ Isotype Control (Cat. No. 555574; dashed line histogram) or with PE Mouse Anti-Human HLA-DR (Cat. No. 555812/560943; solid line histogram). Fluorescent histograms showing expression of HLA-DR (or Ig isotype staining) were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan™ system.
Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS™ Lysing Solution (Cat. No. 349202) and stained with PE Mouse IgG2a, κ Isotype Control (Cat. No. 555574; dashed line histogram) or with PE Mouse Anti-Human HLA-DR (Cat. No. 555812/560943; solid line histogram). Fluorescent histograms showing expression of HLA-DR (or Ig isotype staining) were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan™ system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The G46-6 monoclonal antibody specifically binds to HLA-DR, a major histocompatibility complex (MHC) class II antigen. HLA-DR antigens are encoded by genes within the Human Leukocyte Antigen (HLA) Complex located on chromosome 6. HLA-DR is a transmembrane heterodimeric glycoprotein composed of an α chain (36 kDa) and a β subunit (27 kDa) expressed primarily on antigen presenting cells: B cells, dendritic cells, monocytes, macrophages, and thymic epithelial cells. HLA-DR is also expressed on activated T cells. This molecule plays a major role in mediating cellular interactions during antigen presentation to CD4-positive T cells.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.